TY - JOUR
T1 - International Summit on Laparoscopic Pancreatic Resection (ISLPR) “Coimbatore Summit Statements”
AU - Palanivelu, Chinnusamy
AU - Takaori, Kyoichi
AU - Abu Hilal, Mohammad
AU - Kooby, David A.
AU - Wakabayashi, Go
AU - Agarwal, Anil
AU - Berti, Stefano
AU - Besselink, Marc G.
AU - Chen, Kuo Hsin
AU - Gumbs, Andrew A.
AU - Han, Ho-Seong
AU - Honda, Goro
AU - Khatkov, Igor
AU - Kim, Hong Jin
AU - Li, Jiang Tao
AU - Duy Long, Tran Cong
AU - Machado, Marcel Autran
AU - Matsushita, Akira
AU - Menon, Krish
AU - Min-Hua, Zheng
AU - Nakamura, Masafumi
AU - Nagakawa, Yuichi
AU - Pekolj, Juan
AU - Poves, Ignasi
AU - Rahman, Shahidur
AU - Rong, Liu
AU - Sa Cunha, Antonio
AU - Senthilnathan, Palanisamy
AU - Shrikhande, Shailesh V.
AU - Gurumurthy, S. Srivatsan
AU - Sup Yoon, Dong
AU - Yoon, Yoo-Seok
AU - Khatri, Vijay P.
PY - 2018
Y1 - 2018
N2 - The International Summit on Laparoscopic Pancreatic Resection (ISLPR) was held in Coimbatore, India, on 7th and 8th of October 2016 and thirty international experts who regularly perform laparoscopic pancreatic resections participated in ISPLR from four continents, i.e., South and North America, Europe and Asia. Prior to ISLPR, the first conversation among the experts was made online on August 26th, 2016 and the structures of ISPLR were developed. The aims of ISPLR were; i) to identify indications and optimal case selection criteria for minimally invasive pancreatic resection (MIPR) in the setting of both benign and malignant diseases; ii) standardization of techniques to increase the safety of MIPR; iii) identification of common problems faced during MIPR and developing associated management strategies; iv) development of clinical protocols to allow early identification of complications and develop the accompanying management plan to minimize morbidity and mortality. As a process for interactive discussion, the experts were requested to complete an online questionnaire consisting of 65 questions about the various technical aspects of laparoscopic pancreatic resections. Two further web-based meetings were conducted prior to ISPLR. Through further discussion during ISPLR, we have created productive statements regarding the topics of Disease, Implementation, Patients, Techniques, and Instrumentations (DIPTI) and hereby publish them as “Coimbatore Summit Statements”.
AB - The International Summit on Laparoscopic Pancreatic Resection (ISLPR) was held in Coimbatore, India, on 7th and 8th of October 2016 and thirty international experts who regularly perform laparoscopic pancreatic resections participated in ISPLR from four continents, i.e., South and North America, Europe and Asia. Prior to ISLPR, the first conversation among the experts was made online on August 26th, 2016 and the structures of ISPLR were developed. The aims of ISPLR were; i) to identify indications and optimal case selection criteria for minimally invasive pancreatic resection (MIPR) in the setting of both benign and malignant diseases; ii) standardization of techniques to increase the safety of MIPR; iii) identification of common problems faced during MIPR and developing associated management strategies; iv) development of clinical protocols to allow early identification of complications and develop the accompanying management plan to minimize morbidity and mortality. As a process for interactive discussion, the experts were requested to complete an online questionnaire consisting of 65 questions about the various technical aspects of laparoscopic pancreatic resections. Two further web-based meetings were conducted prior to ISPLR. Through further discussion during ISPLR, we have created productive statements regarding the topics of Disease, Implementation, Patients, Techniques, and Instrumentations (DIPTI) and hereby publish them as “Coimbatore Summit Statements”.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85040623524&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/29371066
U2 - 10.1016/j.suronc.2017.12.001
DO - 10.1016/j.suronc.2017.12.001
M3 - Article
C2 - 29371066
SN - 0960-7404
VL - 27
SP - A10-A15
JO - Surgical Oncology
JF - Surgical Oncology
IS - 1
ER -